Search

Filters
Clear All
  • 6

Phase

  • 2
  • 4
  • 6
  • 1

Found 6 Leslie Hulvershorn, MD, MSc trials

A listing of Leslie Hulvershorn, MD, MSc medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

L
Leslie Hulvershorn, MD, MSc
10 years - 17 years
All genders
Interventional
The purpose of this study is to investigate the use of an investigational medication for treating major depressive episodes in children and teenagers with bipolar disorder. This study will involve pediatric patients aged 10 to 17 years who have been diagnosed with either bipolar I or bipolar II disorder. Bipolar …
L
Leslie Hulvershorn, MD, MSc
12 years - 100 years
All genders
Interventional
What is the purpose of this study?This project seeks to address the increasing risk of overdose death, substance use disorder (SUD), and opioid use disorder (OUD) in adolescents. The investigators believe that pediatric primary care providers (PCP) could play an important role in helping youth with SUD because most adolescents …
L
Leslie Hulvershorn, MD, MSc
10 years - 17 years
All genders
Interventional
This study investigates the use of an investigational medication for treating depressive episodes in young people aged 10 to 17 years with Bipolar I Disorder. The study aims to see if the investigational medication is safe and works well in young people.Bipolar I Disorder is a mental health condition that …
L
Leslie Hulvershorn, MD, MSc
10 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and tolerability of an investigational medication in young people with schizophrenia or bipolar disorder. Schizophrenia is a mental disorder that affects how a person thinks, feels, and behaves. Bipolar disorder is a condition that causes extreme mood swings, including emotional highs (mania or hypomania) and …
L
Leslie Hulvershorn, MD, MSc
5 years - 17 years
All genders
Interventional
This is a multicenter study in pediatric patients aged 5 to 17 years with a primary diagnosis of Autism Spectrum Disorder associated with irritability to evaluate the efficacy of high and low doses of lumateperone compared to placebo for the treatment of irritability associated with Autism Spectrum Disorder and to …
 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
L
Leslie Hulvershorn, MD, MSc
10 years - 17 years
All genders
Phase 3
To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine